+Search query
-Structure paper
Title | Rivastigmine and metabolite analogues with putative Alzheimer's disease-modifying properties in a Caenorhabditis elegans model. |
---|---|
Journal, issue, pages | Commun Chem, Year 2019 |
Publish date | Nov 14, 2017 (structure data deposition date) |
![]() | Dighe, S.N. / de la Mora, E. / Chan, S. / Kantham, S. / McColl, M. / Veliyath, S.K. / Miles, J.A. / Nessar, Z. / McGeary, R.P. / Silman, I. ...Dighe, S.N. / de la Mora, E. / Chan, S. / Kantham, S. / McColl, M. / Veliyath, S.K. / Miles, J.A. / Nessar, Z. / McGeary, R.P. / Silman, I. / Parat, M.O. / Weik, M. / Brazzolotto, X. / Ros, B.P. |
![]() | ![]() |
Methods | X-ray diffraction |
Resolution | 2.7 Å |
Structure data | ![]() PDB-6ez2: |
Chemicals | ![]() ChemComp-NAG: ![]() ChemComp-GOL: ![]() ChemComp-CL: ![]() ChemComp-EDO: ![]() ChemComp-HOH: |
Source |
|
![]() | HYDROLASE / Butyrylcholinesterase / rivastigmine analogues / Alzheimer disease / central nervous system / inhibitor. |